|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ABLIM3-AZU1 (FusionGDB2 ID:HG22885TG566) |
Fusion Gene Summary for ABLIM3-AZU1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ABLIM3-AZU1 | Fusion gene ID: hg22885tg566 | Hgene | Tgene | Gene symbol | ABLIM3 | AZU1 | Gene ID | 22885 | 566 |
Gene name | actin binding LIM protein family member 3 | azurocidin 1 | |
Synonyms | HMFN1661 | AZAMP|AZU|CAP37|HBP|HUMAZUR|NAZC|hHBP | |
Cytomap | ('ABLIM3')('AZU1') 5q32 | 19p13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | actin-binding LIM protein 3abLIM-3 | azurocidincationic antimicrobial protein 37cationic antimicrobial protein CAP37heparin-binding proteinneutrophil azurocidin | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | P20160 | |
Ensembl transtripts involved in fusion gene | ENST00000309868, ENST00000326685, ENST00000356541, ENST00000504238, ENST00000506113, ENST00000508983, ENST00000517451, ENST00000519549, | ||
Fusion gene scores | * DoF score | 4 X 4 X 3=48 | 3 X 2 X 3=18 |
# samples | 4 | 4 | |
** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/18*10)=1.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: ABLIM3 [Title/Abstract] AND AZU1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ABLIM3(148627492)-AZU1(828230), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ABLIM3-AZU1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ABLIM3-AZU1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ABLIM3-AZU1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ABLIM3-AZU1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | AZU1 | GO:0006508 | proteolysis | 21550830 |
Tgene | AZU1 | GO:0008347 | glial cell migration | 12465046 |
Tgene | AZU1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 24008408 |
Tgene | AZU1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 12465046 |
Tgene | AZU1 | GO:0045785 | positive regulation of cell adhesion | 12826073|15879141 |
Tgene | AZU1 | GO:0045860 | positive regulation of protein kinase activity | 24008408 |
Tgene | AZU1 | GO:0050725 | positive regulation of interleukin-1 beta biosynthetic process | 12465046 |
Tgene | AZU1 | GO:0050754 | positive regulation of fractalkine biosynthetic process | 12465046 |
Tgene | AZU1 | GO:0050766 | positive regulation of phagocytosis | 12465046 |
Tgene | AZU1 | GO:0070944 | neutrophil mediated killing of bacterium | 2312733 |
Fusion gene breakpoints across ABLIM3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across AZU1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-C8-A12X-01A | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + |
Top |
Fusion Gene ORF analysis for ABLIM3-AZU1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000309868 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + |
In-frame | ENST00000326685 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + |
In-frame | ENST00000356541 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + |
In-frame | ENST00000504238 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + |
In-frame | ENST00000506113 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + |
In-frame | ENST00000508983 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + |
In-frame | ENST00000517451 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + |
intron-3CDS | ENST00000519549 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000326685 | ABLIM3 | chr5 | 148627492 | + | ENST00000233997 | AZU1 | chr19 | 828230 | + | 2511 | 1673 | 259 | 2370 | 703 |
ENST00000356541 | ABLIM3 | chr5 | 148627492 | + | ENST00000233997 | AZU1 | chr19 | 828230 | + | 2455 | 1617 | 251 | 2314 | 687 |
ENST00000309868 | ABLIM3 | chr5 | 148627492 | + | ENST00000233997 | AZU1 | chr19 | 828230 | + | 2776 | 1938 | 239 | 2635 | 798 |
ENST00000506113 | ABLIM3 | chr5 | 148627492 | + | ENST00000233997 | AZU1 | chr19 | 828230 | + | 3019 | 2181 | 482 | 2878 | 798 |
ENST00000504238 | ABLIM3 | chr5 | 148627492 | + | ENST00000233997 | AZU1 | chr19 | 828230 | + | 2479 | 1641 | 275 | 2338 | 687 |
ENST00000508983 | ABLIM3 | chr5 | 148627492 | + | ENST00000233997 | AZU1 | chr19 | 828230 | + | 2487 | 1649 | 49 | 2346 | 765 |
ENST00000517451 | ABLIM3 | chr5 | 148627492 | + | ENST00000233997 | AZU1 | chr19 | 828230 | + | 2719 | 1881 | 2359 | 1292 | 355 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000326685 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + | 0.02446399 | 0.97553605 |
ENST00000356541 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + | 0.029264534 | 0.9707355 |
ENST00000309868 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + | 0.013013917 | 0.9869861 |
ENST00000506113 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + | 0.00969195 | 0.990308 |
ENST00000504238 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + | 0.024338929 | 0.97566104 |
ENST00000508983 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + | 0.013139925 | 0.9868601 |
ENST00000517451 | ENST00000233997 | ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828230 | + | 0.35011834 | 0.64988166 |
Top |
Fusion Genomic Features for ABLIM3-AZU1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828229 | + | 0.021719752 | 0.9782802 |
ABLIM3 | chr5 | 148627492 | + | AZU1 | chr19 | 828229 | + | 0.021719752 | 0.9782802 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ABLIM3-AZU1 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:148627492/chr19:828230) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | AZU1 |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: This is a neutrophil granule-derived antibacterial and monocyte- and fibroblast-specific chemotactic glycoprotein. Binds heparin. The cytotoxic action is limited to many species of Gram-negative bacteria; this specificity may be explained by a strong affinity of the very basic N-terminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial outer envelope. It may play a role in mediating recruitment of monocytes in the second wave of inflammation. Has antibacterial activity against the Gram-negative bacterium P.aeruginosa, this activity is inhibited by LPS from P.aeruginosa. Acting alone, it does not have antimicrobial activity against the Gram-negative bacteria A.actinomycetemcomitans ATCC 29532, A.actinomycetemcomitans NCTC 9709, A.actinomycetemcomitans FDC-Y4, H.aphrophilus ATCC 13252, E.corrodens ATCC 23834, C.sputigena ATCC 33123, Capnocytophaga sp ATCC 33124, Capnocytophaga sp ATCC 27872 or E.coli ML-35. Has antibacterial activity against C.sputigena ATCC 33123 when acting synergistically with either elastase or cathepsin G. {ECO:0000269|PubMed:1399008, ECO:0000269|PubMed:1937776, ECO:0000269|PubMed:2312733}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000309868 | + | 18 | 24 | 149_208 | 566 | 684.0 | Domain | LIM zinc-binding 3 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000309868 | + | 18 | 24 | 208_268 | 566 | 684.0 | Domain | LIM zinc-binding 4 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000309868 | + | 18 | 24 | 21_80 | 566 | 684.0 | Domain | LIM zinc-binding 1 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000309868 | + | 18 | 24 | 80_140 | 566 | 684.0 | Domain | LIM zinc-binding 2 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000326685 | + | 15 | 21 | 149_208 | 471 | 589.0 | Domain | LIM zinc-binding 3 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000326685 | + | 15 | 21 | 208_268 | 471 | 589.0 | Domain | LIM zinc-binding 4 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000326685 | + | 15 | 21 | 21_80 | 471 | 589.0 | Domain | LIM zinc-binding 1 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000326685 | + | 15 | 21 | 80_140 | 471 | 589.0 | Domain | LIM zinc-binding 2 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000356541 | + | 14 | 20 | 149_208 | 455 | 545.0 | Domain | LIM zinc-binding 3 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000356541 | + | 14 | 20 | 208_268 | 455 | 545.0 | Domain | LIM zinc-binding 4 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000356541 | + | 14 | 20 | 21_80 | 455 | 545.0 | Domain | LIM zinc-binding 1 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000356541 | + | 14 | 20 | 80_140 | 455 | 545.0 | Domain | LIM zinc-binding 2 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000504238 | + | 13 | 19 | 149_208 | 455 | 545.0 | Domain | LIM zinc-binding 3 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000504238 | + | 13 | 19 | 208_268 | 455 | 545.0 | Domain | LIM zinc-binding 4 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000504238 | + | 13 | 19 | 21_80 | 455 | 545.0 | Domain | LIM zinc-binding 1 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000504238 | + | 13 | 19 | 80_140 | 455 | 545.0 | Domain | LIM zinc-binding 2 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000506113 | + | 17 | 23 | 149_208 | 566 | 684.0 | Domain | LIM zinc-binding 3 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000506113 | + | 17 | 23 | 208_268 | 566 | 684.0 | Domain | LIM zinc-binding 4 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000506113 | + | 17 | 23 | 21_80 | 566 | 684.0 | Domain | LIM zinc-binding 1 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000506113 | + | 17 | 23 | 80_140 | 566 | 684.0 | Domain | LIM zinc-binding 2 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000508983 | + | 16 | 22 | 149_208 | 533 | 651.0 | Domain | LIM zinc-binding 3 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000508983 | + | 16 | 22 | 208_268 | 533 | 651.0 | Domain | LIM zinc-binding 4 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000508983 | + | 16 | 22 | 21_80 | 533 | 651.0 | Domain | LIM zinc-binding 1 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000508983 | + | 16 | 22 | 80_140 | 533 | 651.0 | Domain | LIM zinc-binding 2 |
Tgene | AZU1 | chr5:148627492 | chr19:828230 | ENST00000233997 | 0 | 5 | 27_244 | 19 | 252.0 | Domain | Peptidase S1 | |
Tgene | AZU1 | chr5:148627492 | chr19:828230 | ENST00000233997 | 0 | 5 | 46_70 | 19 | 252.0 | Region | Possesses antibiotic activity |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000309868 | + | 18 | 24 | 615_683 | 566 | 684.0 | Domain | HP |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000326685 | + | 15 | 21 | 615_683 | 471 | 589.0 | Domain | HP |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000356541 | + | 14 | 20 | 615_683 | 455 | 545.0 | Domain | HP |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000504238 | + | 13 | 19 | 615_683 | 455 | 545.0 | Domain | HP |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000506113 | + | 17 | 23 | 615_683 | 566 | 684.0 | Domain | HP |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000508983 | + | 16 | 22 | 615_683 | 533 | 651.0 | Domain | HP |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000517451 | + | 3 | 9 | 149_208 | 52 | 170.0 | Domain | LIM zinc-binding 3 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000517451 | + | 3 | 9 | 208_268 | 52 | 170.0 | Domain | LIM zinc-binding 4 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000517451 | + | 3 | 9 | 21_80 | 52 | 170.0 | Domain | LIM zinc-binding 1 |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000517451 | + | 3 | 9 | 615_683 | 52 | 170.0 | Domain | HP |
Hgene | ABLIM3 | chr5:148627492 | chr19:828230 | ENST00000517451 | + | 3 | 9 | 80_140 | 52 | 170.0 | Domain | LIM zinc-binding 2 |
Top |
Fusion Gene Sequence for ABLIM3-AZU1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>523_523_1_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000309868_AZU1_chr19_828230_ENST00000233997_length(transcript)=2776nt_BP=1938nt CTGCCAACCCGCGAGCCCGCATCATGGATGTCGAGCTCCCCTATTTCGCATTGCTAGCCCTGGAATTCGAGACCCCAGACGAGGACCAGG ATTCATGAAATCAGTCGCAGGGGCCGGGGCAGGGGCCTCTGGCTCCCGACACTGGCCGAGAGGTGATGAGTGAGGTTCGAAGAACGGAAG ATTTAAAAAGCAGCCGGGGCCTCCGTATTGAATGAAAGACCCAGTGCAAAGACATCACCATGAACACTAGCATTCCTTATCAGCAGAATC CTTACAATCCACGGGGCAGCTCCAATGTCATCCAGTGCTACCGCTGTGGAGACACCTGCAAAGGGGAAGTGGTCCGCGTGCACAACAACC ACTTCCACATCAGATGCTTCACCTGTCAAGTATGTGGCTGTGGCCTGGCCCAGTCAGGCTTCTTCTTCAAGAACCAGGAGTACATCTGCA CCCAGGACTACCAGCAACTCTATGGCACCCGCTGTGACAGCTGCCGGGACTTCATCACAGGCGAAGTCATCTCGGCCCTGGGCCGCACTT ACCACCCCAAGTGCTTCGTGTGCAGCTTGTGCAGGAAGCCTTTCCCCATTGGAGACAAGGTGACCTTCAGCGGTAAAGAATGTGTGTGCC AAACGTGCTCCCAGTCCATGGCCAGCAGTAAGCCCATCAAGATTCGTGGACCAAGCCACTGTGCCGGGTGCAAGGAGGAGATCAAGCACG GCCAGTCACTCCTGGCTCTGGACAAGCAGTGGCACGTCAGCTGCTTCAAGTGCCAGACCTGCAGCGTCATCCTCACCGGGGAGTATATCA GCAAGGATGGTGTTCCATACTGTGAGTCCGACTACCATGCCCAGTTTGGCATTAAATGTGAGACTTGTGACCGATACATCAGTGGCAGAG TCTTGGAGGCAGGAGGGAAGCACTACCACCCAACCTGTGCCAGGTGTGTACGCTGCCACCAGATGTTCACCGAAGGAGAGGAAATGTACC TCACAGGTTCCGAGGTTTGGCACCCCATCTGCAAACAGGCAGCCCGGGCAGAGAAGAAGTTAAAGCATAGACGGACATCTGAAACCTCCA TCTCACCCCCTGGATCCAGCATTGGGTCACCCAACCGAGTCATCTGCGCTAAAGTGGATAATGAGATCCTTAATTACAAAGACCTGGCGG CTCTCCCCAAGGTTAAGTCTATCTACGAGGTACAACGCCCCGACCTCATTTCCTATGAGCCTCATTCCAGATACATGTCCGACGAGATGC TGGAGAGATGTGGCTATGGAGAGTCGCTGGGAACATTATCTCCCTACTCCCAGGACATCTACGAGAACCTGGACCTCCGGCAGAGACGGG CCTCCAGCCCGGGGTACATAGACTCCCCCACCTACAGCCGGCAGGGCATGTCCCCCACCTTCTCCCGCTCACCTCACCACTACTACCGCT CTGGGCCCGAGAGTGGCCGGAGCTCTCCATACCATAGCCAGTTAGATGTGAGGTCCTCCACTCCAACCTCTTACCAGGCTCCCAAGCACT TTCACATCCCAGCTGGAGACAGTAACATCTACCGGAAACCCCCGATCTACAAACGGCATGGTGATTTGTCTACAGCAACCAAGAGCAAAA CAAGTGAAGACATCAGCCAGACCTCCAAGTACAGTCCCATCTACTCGCCAGACCCCTACTATGCTTCGGAGTCTGAGTACTGGACCTACC ATGGGTCCCCCAAAGTGCCCCGAGCCAGAAGGTTCTCGTCTGGAGGAGAGGAGGATGATTTTGACCGCAGCATGCACAAGCTCCAAAGTG GAATTGGCCGGCTGATTCTGAAGGAAGAAATGAAGGCCCGGTCGAGCTCCTATGCAGATCCCTGGACCCCTCCCCGGAGCTCCACCAGCA GCCGGGAAGCCCTGCACACAGCTGGCTATGAGATGTCCCTCAATGGCTGCTCCAGCCCCCTTTTGGACATCGTTGGCGGCCGGAAGGCGA GGCCCCGCCAGTTCCCGTTCCTGGCCTCCATTCAGAATCAAGGCAGGCACTTCTGCGGGGGTGCCCTGATCCATGCCCGCTTCGTGATGA CCGCGGCCAGCTGCTTCCAAAGCCAGAACCCCGGGGTTAGCACCGTGGTGCTGGGTGCCTATGACCTGAGGCGGCGGGAGAGGCAGTCCC GCCAGACGTTTTCCATCAGCAGCATGAGCGAGAATGGCTACGACCCCCAGCAGAACCTGAACGACCTGATGCTGCTTCAGCTGGACCGTG AGGCCAACCTCACCAGCAGCGTGACGATACTGCCACTGCCTCTGCAGAACGCCACGGTGGAAGCCGGCACCAGATGCCAGGTGGCCGGCT GGGGGAGCCAGCGCAGTGGGGGGCGTCTCTCCCGTTTTCCCAGGTTTGTCAACGTGACTGTGACCCCCGAGGACCAGTGTCGCCCCAACA ACGTGTGCACCGGTGTGCTCACCCGCCGCGGTGGCATCTGCAATGGGGACGGGGGCACCCCCCTCGTCTGCGAGGGCCTGGCCCACGGCG TGGCCTCCTTTTCCCTGGGGCCCTGTGGCCGAGGCCCTGACTTCTTCACCCGAGTGGCGCTCTTCCGAGACTGGATCGATGGTGTTCTCA ACAACCCGGGACCGGGGCCAGCCTAGGGGGGCCTGTGACCTCCCATGGAGCCCAGCCCCGCCCTCCACACCTCCGGCGCTCCGCACCCAC >523_523_1_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000309868_AZU1_chr19_828230_ENST00000233997_length(amino acids)=798AA_BP=567 MNTSIPYQQNPYNPRGSSNVIQCYRCGDTCKGEVVRVHNNHFHIRCFTCQVCGCGLAQSGFFFKNQEYICTQDYQQLYGTRCDSCRDFIT GEVISALGRTYHPKCFVCSLCRKPFPIGDKVTFSGKECVCQTCSQSMASSKPIKIRGPSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQT CSVILTGEYISKDGVPYCESDYHAQFGIKCETCDRYISGRVLEAGGKHYHPTCARCVRCHQMFTEGEEMYLTGSEVWHPICKQAARAEKK LKHRRTSETSISPPGSSIGSPNRVICAKVDNEILNYKDLAALPKVKSIYEVQRPDLISYEPHSRYMSDEMLERCGYGESLGTLSPYSQDI YENLDLRQRRASSPGYIDSPTYSRQGMSPTFSRSPHHYYRSGPESGRSSPYHSQLDVRSSTPTSYQAPKHFHIPAGDSNIYRKPPIYKRH GDLSTATKSKTSEDISQTSKYSPIYSPDPYYASESEYWTYHGSPKVPRARRFSSGGEEDDFDRSMHKLQSGIGRLILKEEMKARSSSYAD PWTPPRSSTSSREALHTAGYEMSLNGCSSPLLDIVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGA YDLRRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVT -------------------------------------------------------------- >523_523_2_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000326685_AZU1_chr19_828230_ENST00000233997_length(transcript)=2511nt_BP=1673nt GAGCGGCCGCGCCCCCTGCGCTGCCAACCCGCGAGCCCGCATCATGGATGTCGAGCTCCCCTATTTCGCATTGCTAGCCCTGGAATTCGA GACCCCAGACGAGGACCAGGATTCATGAAATCAGTCGCAGGGGCCGGGGCAGGGGCCTCTGGCTCCCGACACTGGCCGAGAGGTGATGAG TGAGGTTCGAAGAACGGAAGATTTAAAAAGCAGCCGGGGCCTCCGTATTGAATGAAAGACCCAGTGCAAAGACATCACCATGAACACTAG CATTCCTTATCAGCAGAATCCTTACAATCCACGGGGCAGCTCCAATGTCATCCAGTGCTACCGCTGTGGAGACACCTGCAAAGGGGAAGT GGTCCGCGTGCACAACAACCACTTCCACATCAGATGCTTCACCTGTCAAGTATGTGGCTGTGGCCTGGCCCAGTCAGGCTTCTTCTTCAA GAACCAGGAGTACATCTGCACCCAGGACTACCAGCAACTCTATGGCACCCGCTGTGACAGCTGCCGGGACTTCATCACAGGCGAAGTCAT CTCGGCCCTGGGCCGCACTTACCACCCCAAGTGCTTCGTGTGCAGCTTGTGCAGGAAGCCTTTCCCCATTGGAGACAAGGTGACCTTCAG CGGTAAAGAATGTGTGTGCCAAACGTGCTCCCAGTCCATGGCCAGCAGTAAGCCCATCAAGATTCGTGGACCAAGCCACTGTGCCGGGTG CAAGGAGGAGATCAAGCACGGCCAGTCACTCCTGGCTCTGGACAAGCAGTGGCACGTCAGCTGCTTCAAGTGCCAGACCTGCAGCGTCAT CCTCACCGGGGAGTATATCAGCAAGGATGGTGTTCCATACTGTGAGTCCGACTACCATGCCCAGTTTGGCATTAAATGTGAGACTTGTGA CCGATACATCAGTGGCAGAGTCTTGGAGGCAGGAGGGAAGCACTACCACCCAACCTGTGCCAGGTGTGTACGCTGCCACCAGATGTTCAC CGAAGGAGAGGAAATGTACCTCACAGGTTCCGAGGTTTGGCACCCCATCTGCAAACAGGCAGCCCGGGCAGAGAAGAAGTTAAAGCATAG ACGGACATCTGAAACCTCCATCTCACCCCCTGGATCCAGCATTGGGTCACCCAACCGAGTCATCTGCGACATCTACGAGAACCTGGACCT CCGGCAGAGACGGGCCTCCAGCCCGGGGTACATAGACTCCCCCACCTACAGCCGGCAGGGCATGTCCCCCACCTTCTCCCGCTCACCTCA CCACTACTACCGCTCTGCTGGAGACAGTAACATCTACCGGAAACCCCCGATCTACAAACGGCATGGTGATTTGTCTACAGCAACCAAGAG CAAAACAAGTGAAGACATCAGCCAGACCTCCAAGTACAGTCCCATCTACTCGCCAGACCCCTACTATGCTTCGGAGTCTGAGTACTGGAC CTACCATGGGTCCCCCAAAGTGCCCCGAGCCAGAAGGTTCTCGTCTGGAGGAGAGGAGGATGATTTTGACCGCAGCATGCACAAGCTCCA AAGTGGAATTGGCCGGCTGATTCTGAAGGAAGAAATGAAGGCCCGGTCGAGCTCCTATGCAGATCCCTGGACCCCTCCCCGGAGCTCCAC CAGCAGCCGGGAAGCCCTGCACACAGCTGGCTATGAGATGTCCCTCAATGGCTGCTCCAGCCCCCTTTTGGACATCGTTGGCGGCCGGAA GGCGAGGCCCCGCCAGTTCCCGTTCCTGGCCTCCATTCAGAATCAAGGCAGGCACTTCTGCGGGGGTGCCCTGATCCATGCCCGCTTCGT GATGACCGCGGCCAGCTGCTTCCAAAGCCAGAACCCCGGGGTTAGCACCGTGGTGCTGGGTGCCTATGACCTGAGGCGGCGGGAGAGGCA GTCCCGCCAGACGTTTTCCATCAGCAGCATGAGCGAGAATGGCTACGACCCCCAGCAGAACCTGAACGACCTGATGCTGCTTCAGCTGGA CCGTGAGGCCAACCTCACCAGCAGCGTGACGATACTGCCACTGCCTCTGCAGAACGCCACGGTGGAAGCCGGCACCAGATGCCAGGTGGC CGGCTGGGGGAGCCAGCGCAGTGGGGGGCGTCTCTCCCGTTTTCCCAGGTTTGTCAACGTGACTGTGACCCCCGAGGACCAGTGTCGCCC CAACAACGTGTGCACCGGTGTGCTCACCCGCCGCGGTGGCATCTGCAATGGGGACGGGGGCACCCCCCTCGTCTGCGAGGGCCTGGCCCA CGGCGTGGCCTCCTTTTCCCTGGGGCCCTGTGGCCGAGGCCCTGACTTCTTCACCCGAGTGGCGCTCTTCCGAGACTGGATCGATGGTGT TCTCAACAACCCGGGACCGGGGCCAGCCTAGGGGGGCCTGTGACCTCCCATGGAGCCCAGCCCCGCCCTCCACACCTCCGGCGCTCCGCA >523_523_2_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000326685_AZU1_chr19_828230_ENST00000233997_length(amino acids)=703AA_BP=472 MNTSIPYQQNPYNPRGSSNVIQCYRCGDTCKGEVVRVHNNHFHIRCFTCQVCGCGLAQSGFFFKNQEYICTQDYQQLYGTRCDSCRDFIT GEVISALGRTYHPKCFVCSLCRKPFPIGDKVTFSGKECVCQTCSQSMASSKPIKIRGPSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQT CSVILTGEYISKDGVPYCESDYHAQFGIKCETCDRYISGRVLEAGGKHYHPTCARCVRCHQMFTEGEEMYLTGSEVWHPICKQAARAEKK LKHRRTSETSISPPGSSIGSPNRVICDIYENLDLRQRRASSPGYIDSPTYSRQGMSPTFSRSPHHYYRSAGDSNIYRKPPIYKRHGDLST ATKSKTSEDISQTSKYSPIYSPDPYYASESEYWTYHGSPKVPRARRFSSGGEEDDFDRSMHKLQSGIGRLILKEEMKARSSSYADPWTPP RSSTSSREALHTAGYEMSLNGCSSPLLDIVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDLRR RERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPED -------------------------------------------------------------- >523_523_3_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000356541_AZU1_chr19_828230_ENST00000233997_length(transcript)=2455nt_BP=1617nt GCGCCCCCTGCGCTGCCAACCCGCGAGCCCGCATCATGGATGTCGAGCTCCCCTATTTCGCATTGCTAGCCCTGGAATTCGAGACCCCAG ACGAGGACCAGGATTCATGAAATCAGTCGCAGGGGCCGGGGCAGGGGCCTCTGGCTCCCGACACTGGCCGAGAGGTGATGAGTGAGGTTC GAAGAACGGAAGATTTAAAAAGCAGCCGGGGCCTCCGTATTGAATGAAAGACCCAGTGCAAAGACATCACCATGAACACTAGCATTCCTT ATCAGCAGAATCCTTACAATCCACGGGGCAGCTCCAATGTCATCCAGTGCTACCGCTGTGGAGACACCTGCAAAGGGGAAGTGGTCCGCG TGCACAACAACCACTTCCACATCAGATGCTTCACCTGTCAAGTATGTGGCTGTGGCCTGGCCCAGTCAGGCTTCTTCTTCAAGAACCAGG AGTACATCTGCACCCAGGACTACCAGCAACTCTATGGCACCCGCTGTGACAGCTGCCGGGACTTCATCACAGGCGAAGTCATCTCGGCCC TGGGCCGCACTTACCACCCCAAGTGCTTCGTGTGCAGCTTGTGCAGGAAGCCTTTCCCCATTGGAGACAAGGTGACCTTCAGCGGTAAAG AATGTGTGTGCCAAACGTGCTCCCAGTCCATGGCCAGCAGTAAGCCCATCAAGATTCGTGGACCAAGCCACTGTGCCGGGTGCAAGGAGG AGATCAAGCACGGCCAGTCACTCCTGGCTCTGGACAAGCAGTGGCACGTCAGCTGCTTCAAGTGCCAGACCTGCAGCGTCATCCTCACCG GGGAGTATATCAGCAAGGATGGTGTTCCATACTGTGAGTCCGACTACCATGCCCAGTTTGGCATTAAATGTGAGACTTGTGACCGATACA TCAGTGGCAGAGTCTTGGAGGCAGGAGGGAAGCACTACCACCCAACCTGTGCCAGGTGTGTACGCTGCCACCAGATGTTCACCGAAGGAG AGGAAATGTACCTCACAGGTTCCGAGGTTTGGCACCCCATCTGCAAACAGGCAGCCCGGGCAGAGAAGAAGTTAAAGCATAGACGGACAT CTGAAACCTCCATCTCACCCCCTGGATCCAGCATTGGGTCACCCAACCGAGTCATCTGCGACATCTACGAGAACCTGGACCTCCGGCAGA GACGGGCCTCCAGCCCGGGGTACATAGACTCCCCCACCTACAGCCGGCAGGGCATGTCCCCCACCTTCTCCCGCTCACCTCACCACTACT ACCGCTCTGGTGATTTGTCTACAGCAACCAAGAGCAAAACAAGTGAAGACATCAGCCAGACCTCCAAGTACAGTCCCATCTACTCGCCAG ACCCCTACTATGCTTCGGAGTCTGAGTACTGGACCTACCATGGGTCCCCCAAAGTGCCCCGAGCCAGAAGGTTCTCGTCTGGAGGAGAGG AGGATGATTTTGACCGCAGCATGCACAAGCTCCAAAGTGGAATTGGCCGGCTGATTCTGAAGGAAGAAATGAAGGCCCGGTCGAGCTCCT ATGCAGATCCCTGGACCCCTCCCCGGAGCTCCACCAGCAGCCGGGAAGCCCTGCACACAGCTGGCTATGAGATGTCCCTCAATGGCTGCT CCAGCCCCCTTTTGGACATCGTTGGCGGCCGGAAGGCGAGGCCCCGCCAGTTCCCGTTCCTGGCCTCCATTCAGAATCAAGGCAGGCACT TCTGCGGGGGTGCCCTGATCCATGCCCGCTTCGTGATGACCGCGGCCAGCTGCTTCCAAAGCCAGAACCCCGGGGTTAGCACCGTGGTGC TGGGTGCCTATGACCTGAGGCGGCGGGAGAGGCAGTCCCGCCAGACGTTTTCCATCAGCAGCATGAGCGAGAATGGCTACGACCCCCAGC AGAACCTGAACGACCTGATGCTGCTTCAGCTGGACCGTGAGGCCAACCTCACCAGCAGCGTGACGATACTGCCACTGCCTCTGCAGAACG CCACGGTGGAAGCCGGCACCAGATGCCAGGTGGCCGGCTGGGGGAGCCAGCGCAGTGGGGGGCGTCTCTCCCGTTTTCCCAGGTTTGTCA ACGTGACTGTGACCCCCGAGGACCAGTGTCGCCCCAACAACGTGTGCACCGGTGTGCTCACCCGCCGCGGTGGCATCTGCAATGGGGACG GGGGCACCCCCCTCGTCTGCGAGGGCCTGGCCCACGGCGTGGCCTCCTTTTCCCTGGGGCCCTGTGGCCGAGGCCCTGACTTCTTCACCC GAGTGGCGCTCTTCCGAGACTGGATCGATGGTGTTCTCAACAACCCGGGACCGGGGCCAGCCTAGGGGGGCCTGTGACCTCCCATGGAGC CCAGCCCCGCCCTCCACACCTCCGGCGCTCCGCACCCACCTCCCACGGCCCCGCCCCTGCCCCCGCTCCGGCCAGAGGGGCCCTGGCTGT >523_523_3_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000356541_AZU1_chr19_828230_ENST00000233997_length(amino acids)=687AA_BP=456 MNTSIPYQQNPYNPRGSSNVIQCYRCGDTCKGEVVRVHNNHFHIRCFTCQVCGCGLAQSGFFFKNQEYICTQDYQQLYGTRCDSCRDFIT GEVISALGRTYHPKCFVCSLCRKPFPIGDKVTFSGKECVCQTCSQSMASSKPIKIRGPSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQT CSVILTGEYISKDGVPYCESDYHAQFGIKCETCDRYISGRVLEAGGKHYHPTCARCVRCHQMFTEGEEMYLTGSEVWHPICKQAARAEKK LKHRRTSETSISPPGSSIGSPNRVICDIYENLDLRQRRASSPGYIDSPTYSRQGMSPTFSRSPHHYYRSGDLSTATKSKTSEDISQTSKY SPIYSPDPYYASESEYWTYHGSPKVPRARRFSSGGEEDDFDRSMHKLQSGIGRLILKEEMKARSSSYADPWTPPRSSTSSREALHTAGYE MSLNGCSSPLLDIVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDLRRRERQSRQTFSISSMSE NGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNVCTGVLTRRG -------------------------------------------------------------- >523_523_4_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000504238_AZU1_chr19_828230_ENST00000233997_length(transcript)=2479nt_BP=1641nt CAATCTGAGGAGCAGGAGGACCGGGGCGCCGGTGTCCTGCCGCCTCCTTCTCCTTGCTCTCACCTGCGCCTATTAGTCCACGCGCCTTCA AGGCCAGGGGCTACAGCCCAGACAGAGAGGGGACAGCAGAGGGAGAGAGAGCACCTGAGGATACAGAGCTGGCACTGGACTGCCTTTTCA CCCCCCAGGTGATGAGTGAGGTTCGAAGAACGGAAGATTTAAAAAGCAGCCGGGGCCTCCGTATTGAATGAAAGACCCAGTGCAAAGACA TCACCATGAACACTAGCATTCCTTATCAGCAGAATCCTTACAATCCACGGGGCAGCTCCAATGTCATCCAGTGCTACCGCTGTGGAGACA CCTGCAAAGGGGAAGTGGTCCGCGTGCACAACAACCACTTCCACATCAGATGCTTCACCTGTCAAGTATGTGGCTGTGGCCTGGCCCAGT CAGGCTTCTTCTTCAAGAACCAGGAGTACATCTGCACCCAGGACTACCAGCAACTCTATGGCACCCGCTGTGACAGCTGCCGGGACTTCA TCACAGGCGAAGTCATCTCGGCCCTGGGCCGCACTTACCACCCCAAGTGCTTCGTGTGCAGCTTGTGCAGGAAGCCTTTCCCCATTGGAG ACAAGGTGACCTTCAGCGGTAAAGAATGTGTGTGCCAAACGTGCTCCCAGTCCATGGCCAGCAGTAAGCCCATCAAGATTCGTGGACCAA GCCACTGTGCCGGGTGCAAGGAGGAGATCAAGCACGGCCAGTCACTCCTGGCTCTGGACAAGCAGTGGCACGTCAGCTGCTTCAAGTGCC AGACCTGCAGCGTCATCCTCACCGGGGAGTATATCAGCAAGGATGGTGTTCCATACTGTGAGTCCGACTACCATGCCCAGTTTGGCATTA AATGTGAGACTTGTGACCGATACATCAGTGGCAGAGTCTTGGAGGCAGGAGGGAAGCACTACCACCCAACCTGTGCCAGGTGTGTACGCT GCCACCAGATGTTCACCGAAGGAGAGGAAATGTACCTCACAGGTTCCGAGGTTTGGCACCCCATCTGCAAACAGGCAGCCCGGGCAGAGA AGAAGTTAAAGCATAGACGGACATCTGAAACCTCCATCTCACCCCCTGGATCCAGCATTGGGTCACCCAACCGAGTCATCTGCGACATCT ACGAGAACCTGGACCTCCGGCAGAGACGGGCCTCCAGCCCGGGGTACATAGACTCCCCCACCTACAGCCGGCAGGGCATGTCCCCCACCT TCTCCCGCTCACCTCACCACTACTACCGCTCTGGTGATTTGTCTACAGCAACCAAGAGCAAAACAAGTGAAGACATCAGCCAGACCTCCA AGTACAGTCCCATCTACTCGCCAGACCCCTACTATGCTTCGGAGTCTGAGTACTGGACCTACCATGGGTCCCCCAAAGTGCCCCGAGCCA GAAGGTTCTCGTCTGGAGGAGAGGAGGATGATTTTGACCGCAGCATGCACAAGCTCCAAAGTGGAATTGGCCGGCTGATTCTGAAGGAAG AAATGAAGGCCCGGTCGAGCTCCTATGCAGATCCCTGGACCCCTCCCCGGAGCTCCACCAGCAGCCGGGAAGCCCTGCACACAGCTGGCT ATGAGATGTCCCTCAATGGCTGCTCCAGCCCCCTTTTGGACATCGTTGGCGGCCGGAAGGCGAGGCCCCGCCAGTTCCCGTTCCTGGCCT CCATTCAGAATCAAGGCAGGCACTTCTGCGGGGGTGCCCTGATCCATGCCCGCTTCGTGATGACCGCGGCCAGCTGCTTCCAAAGCCAGA ACCCCGGGGTTAGCACCGTGGTGCTGGGTGCCTATGACCTGAGGCGGCGGGAGAGGCAGTCCCGCCAGACGTTTTCCATCAGCAGCATGA GCGAGAATGGCTACGACCCCCAGCAGAACCTGAACGACCTGATGCTGCTTCAGCTGGACCGTGAGGCCAACCTCACCAGCAGCGTGACGA TACTGCCACTGCCTCTGCAGAACGCCACGGTGGAAGCCGGCACCAGATGCCAGGTGGCCGGCTGGGGGAGCCAGCGCAGTGGGGGGCGTC TCTCCCGTTTTCCCAGGTTTGTCAACGTGACTGTGACCCCCGAGGACCAGTGTCGCCCCAACAACGTGTGCACCGGTGTGCTCACCCGCC GCGGTGGCATCTGCAATGGGGACGGGGGCACCCCCCTCGTCTGCGAGGGCCTGGCCCACGGCGTGGCCTCCTTTTCCCTGGGGCCCTGTG GCCGAGGCCCTGACTTCTTCACCCGAGTGGCGCTCTTCCGAGACTGGATCGATGGTGTTCTCAACAACCCGGGACCGGGGCCAGCCTAGG GGGGCCTGTGACCTCCCATGGAGCCCAGCCCCGCCCTCCACACCTCCGGCGCTCCGCACCCACCTCCCACGGCCCCGCCCCTGCCCCCGC >523_523_4_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000504238_AZU1_chr19_828230_ENST00000233997_length(amino acids)=687AA_BP=456 MNTSIPYQQNPYNPRGSSNVIQCYRCGDTCKGEVVRVHNNHFHIRCFTCQVCGCGLAQSGFFFKNQEYICTQDYQQLYGTRCDSCRDFIT GEVISALGRTYHPKCFVCSLCRKPFPIGDKVTFSGKECVCQTCSQSMASSKPIKIRGPSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQT CSVILTGEYISKDGVPYCESDYHAQFGIKCETCDRYISGRVLEAGGKHYHPTCARCVRCHQMFTEGEEMYLTGSEVWHPICKQAARAEKK LKHRRTSETSISPPGSSIGSPNRVICDIYENLDLRQRRASSPGYIDSPTYSRQGMSPTFSRSPHHYYRSGDLSTATKSKTSEDISQTSKY SPIYSPDPYYASESEYWTYHGSPKVPRARRFSSGGEEDDFDRSMHKLQSGIGRLILKEEMKARSSSYADPWTPPRSSTSSREALHTAGYE MSLNGCSSPLLDIVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDLRRRERQSRQTFSISSMSE NGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNVCTGVLTRRG -------------------------------------------------------------- >523_523_5_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000506113_AZU1_chr19_828230_ENST00000233997_length(transcript)=3019nt_BP=2181nt GGCCGGGGCAGGGGCCTCTGGCTCCCGACACTGGCCGAGAGGTGGGTTCCGGGGCGGGTCGCTGCTCCTTGAAGCCGGGCGGGGACGCGC TGCCCCCGCCCTGCCTCCCTGTGGTCCACACCCCCTTTGGGCTCCGGAGCCGCTGGGCAGGAATAGTCCGGGGTGCGCGCGAGCAGGCGC TGCCAACCCCACTTCTGCCCGGGATTCCAATCTGAGGAGCAGGAGGACCGGGGCGCCGGTGTCCTGCCGCCTCCTTCTCCTTGCTCTCAC CTGCGCCTATTAGTCCACGCGCCTTCAAGGCCAGGGGCTACAGCCCAGACAGAGAGGGGACAGCAGAGGGAGAGAGAGCACCTGAGGATA CAGAGCTGGCACTGGACTGCCTTTTCACCCCCCAGGTGATGAGTGAGGTTCGAAGAACGGAAGATTTAAAAAGCAGCCGGGGCCTCCGTA TTGAATGAAAGACCCAGTGCAAAGACATCACCATGAACACTAGCATTCCTTATCAGCAGAATCCTTACAATCCACGGGGCAGCTCCAATG TCATCCAGTGCTACCGCTGTGGAGACACCTGCAAAGGGGAAGTGGTCCGCGTGCACAACAACCACTTCCACATCAGATGCTTCACCTGTC AAGTATGTGGCTGTGGCCTGGCCCAGTCAGGCTTCTTCTTCAAGAACCAGGAGTACATCTGCACCCAGGACTACCAGCAACTCTATGGCA CCCGCTGTGACAGCTGCCGGGACTTCATCACAGGCGAAGTCATCTCGGCCCTGGGCCGCACTTACCACCCCAAGTGCTTCGTGTGCAGCT TGTGCAGGAAGCCTTTCCCCATTGGAGACAAGGTGACCTTCAGCGGTAAAGAATGTGTGTGCCAAACGTGCTCCCAGTCCATGGCCAGCA GTAAGCCCATCAAGATTCGTGGACCAAGCCACTGTGCCGGGTGCAAGGAGGAGATCAAGCACGGCCAGTCACTCCTGGCTCTGGACAAGC AGTGGCACGTCAGCTGCTTCAAGTGCCAGACCTGCAGCGTCATCCTCACCGGGGAGTATATCAGCAAGGATGGTGTTCCATACTGTGAGT CCGACTACCATGCCCAGTTTGGCATTAAATGTGAGACTTGTGACCGATACATCAGTGGCAGAGTCTTGGAGGCAGGAGGGAAGCACTACC ACCCAACCTGTGCCAGGTGTGTACGCTGCCACCAGATGTTCACCGAAGGAGAGGAAATGTACCTCACAGGTTCCGAGGTTTGGCACCCCA TCTGCAAACAGGCAGCCCGGGCAGAGAAGAAGTTAAAGCATAGACGGACATCTGAAACCTCCATCTCACCCCCTGGATCCAGCATTGGGT CACCCAACCGAGTCATCTGCGCTAAAGTGGATAATGAGATCCTTAATTACAAAGACCTGGCGGCTCTCCCCAAGGTTAAGTCTATCTACG AGGTACAACGCCCCGACCTCATTTCCTATGAGCCTCATTCCAGATACATGTCCGACGAGATGCTGGAGAGATGTGGCTATGGAGAGTCGC TGGGAACATTATCTCCCTACTCCCAGGACATCTACGAGAACCTGGACCTCCGGCAGAGACGGGCCTCCAGCCCGGGGTACATAGACTCCC CCACCTACAGCCGGCAGGGCATGTCCCCCACCTTCTCCCGCTCACCTCACCACTACTACCGCTCTGGGCCCGAGAGTGGCCGGAGCTCTC CATACCATAGCCAGTTAGATGTGAGGTCCTCCACTCCAACCTCTTACCAGGCTCCCAAGCACTTTCACATCCCAGCTGGAGACAGTAACA TCTACCGGAAACCCCCGATCTACAAACGGCATGGTGATTTGTCTACAGCAACCAAGAGCAAAACAAGTGAAGACATCAGCCAGACCTCCA AGTACAGTCCCATCTACTCGCCAGACCCCTACTATGCTTCGGAGTCTGAGTACTGGACCTACCATGGGTCCCCCAAAGTGCCCCGAGCCA GAAGGTTCTCGTCTGGAGGAGAGGAGGATGATTTTGACCGCAGCATGCACAAGCTCCAAAGTGGAATTGGCCGGCTGATTCTGAAGGAAG AAATGAAGGCCCGGTCGAGCTCCTATGCAGATCCCTGGACCCCTCCCCGGAGCTCCACCAGCAGCCGGGAAGCCCTGCACACAGCTGGCT ATGAGATGTCCCTCAATGGCTGCTCCAGCCCCCTTTTGGACATCGTTGGCGGCCGGAAGGCGAGGCCCCGCCAGTTCCCGTTCCTGGCCT CCATTCAGAATCAAGGCAGGCACTTCTGCGGGGGTGCCCTGATCCATGCCCGCTTCGTGATGACCGCGGCCAGCTGCTTCCAAAGCCAGA ACCCCGGGGTTAGCACCGTGGTGCTGGGTGCCTATGACCTGAGGCGGCGGGAGAGGCAGTCCCGCCAGACGTTTTCCATCAGCAGCATGA GCGAGAATGGCTACGACCCCCAGCAGAACCTGAACGACCTGATGCTGCTTCAGCTGGACCGTGAGGCCAACCTCACCAGCAGCGTGACGA TACTGCCACTGCCTCTGCAGAACGCCACGGTGGAAGCCGGCACCAGATGCCAGGTGGCCGGCTGGGGGAGCCAGCGCAGTGGGGGGCGTC TCTCCCGTTTTCCCAGGTTTGTCAACGTGACTGTGACCCCCGAGGACCAGTGTCGCCCCAACAACGTGTGCACCGGTGTGCTCACCCGCC GCGGTGGCATCTGCAATGGGGACGGGGGCACCCCCCTCGTCTGCGAGGGCCTGGCCCACGGCGTGGCCTCCTTTTCCCTGGGGCCCTGTG GCCGAGGCCCTGACTTCTTCACCCGAGTGGCGCTCTTCCGAGACTGGATCGATGGTGTTCTCAACAACCCGGGACCGGGGCCAGCCTAGG GGGGCCTGTGACCTCCCATGGAGCCCAGCCCCGCCCTCCACACCTCCGGCGCTCCGCACCCACCTCCCACGGCCCCGCCCCTGCCCCCGC >523_523_5_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000506113_AZU1_chr19_828230_ENST00000233997_length(amino acids)=798AA_BP=567 MNTSIPYQQNPYNPRGSSNVIQCYRCGDTCKGEVVRVHNNHFHIRCFTCQVCGCGLAQSGFFFKNQEYICTQDYQQLYGTRCDSCRDFIT GEVISALGRTYHPKCFVCSLCRKPFPIGDKVTFSGKECVCQTCSQSMASSKPIKIRGPSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQT CSVILTGEYISKDGVPYCESDYHAQFGIKCETCDRYISGRVLEAGGKHYHPTCARCVRCHQMFTEGEEMYLTGSEVWHPICKQAARAEKK LKHRRTSETSISPPGSSIGSPNRVICAKVDNEILNYKDLAALPKVKSIYEVQRPDLISYEPHSRYMSDEMLERCGYGESLGTLSPYSQDI YENLDLRQRRASSPGYIDSPTYSRQGMSPTFSRSPHHYYRSGPESGRSSPYHSQLDVRSSTPTSYQAPKHFHIPAGDSNIYRKPPIYKRH GDLSTATKSKTSEDISQTSKYSPIYSPDPYYASESEYWTYHGSPKVPRARRFSSGGEEDDFDRSMHKLQSGIGRLILKEEMKARSSSYAD PWTPPRSSTSSREALHTAGYEMSLNGCSSPLLDIVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGA YDLRRRERQSRQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVT -------------------------------------------------------------- >523_523_6_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000508983_AZU1_chr19_828230_ENST00000233997_length(transcript)=2487nt_BP=1649nt CAGCCGGGGCCTCCGTATTGAATGAAAGACCCAGTGCAAAGACATCACCATGAACACTAGCATTCCTTATCAGCAGAATCCTTACAATCC ACGGGGCAGCTCCAATGTCATCCAGTGCTACCGCTGTGGAGACACCTGCAAAGGGGAAGTGGTCCGCGTGCACAACAACCACTTCCACAT CAGATGCTTCACCTGTCAAGTATGTGGCTGTGGCCTGGCCCAGTCAGGCTTCTTCTTCAAGAACCAGGAGTACATCTGCACCCAGGACTA CCAGCAACTCTATGGCACCCGCTGTGACAGCTGCCGGGACTTCATCACAGGCGAAGTCATCTCGGCCCTGGGCCGCACTTACCACCCCAA GTGCTTCGTGTGCAGCTTGTGCAGGAAGCCTTTCCCCATTGGAGACAAGGTGACCTTCAGCGGTAAAGAATGTGTGTGCCAAACGTGCTC CCAGTCCATGGCCAGCAGTAAGCCCATCAAGATTCGTGGACCAAGCCACTGTGCCGGGTGCAAGGAGGAGATCAAGCACGGCCAGTCACT CCTGGCTCTGGACAAGCAGTGGCACGTCAGCTGCTTCAAGTGCCAGACCTGCAGCGTCATCCTCACCGGGGAGTATATCAGCAAGGATGG TGTTCCATACTGTGAGTCCGACTACCATGCCCAGTTTGGCATTAAATGTGAGACTTGTGACCGATACATCAGTGGCAGAGTCTTGGAGGC AGGAGGGAAGCACTACCACCCAACCTGTGCCAGGTGTGTACGCTGCCACCAGATGTTCACCGAAGGAGAGGAAATGTACCTCACAGGTTC CGAGGTTTGGCACCCCATCTGCAAACAGGCAGCCCGGGCAGAGAAGAAGTTAAAGCATAGACGGACATCTGAAACCTCCATCTCACCCCC TGGATCCAGCATTGGGTCACCCAACCGAGTCATCTGCGCTAAAGTGGATAATGAGATCCTTAATTACAAAGACCTGGCGGCTCTCCCCAA GGTTAAGTCTATCTACGAGGTACAACGCCCCGACCTCATTTCCTATGAGCCTCATTCCAGATACATGTCCGACGAGATGCTGGAGAGATG TGGCTATGGAGAGTCGCTGGGAACATTATCTCCCTACTCCCAGGACATCTACGAGAACCTGGACCTCCGGCAGAGACGGGCCTCCAGCCC GGGGTACATAGACTCCCCCACCTACAGCCGGCAGGGCATGTCCCCCACCTTCTCCCGCTCACCTCACCACTACTACCGCTCTGCTGGAGA CAGTAACATCTACCGGAAACCCCCGATCTACAAACGGCATGGTGATTTGTCTACAGCAACCAAGAGCAAAACAAGTGAAGACATCAGCCA GACCTCCAAGTACAGTCCCATCTACTCGCCAGACCCCTACTATGCTTCGGAGTCTGAGTACTGGACCTACCATGGGTCCCCCAAAGTGCC CCGAGCCAGAAGGTTCTCGTCTGGAGGAGAGGAGGATGATTTTGACCGCAGCATGCACAAGCTCCAAAGTGGAATTGGCCGGCTGATTCT GAAGGAAGAAATGAAGGCCCGGTCGAGCTCCTATGCAGATCCCTGGACCCCTCCCCGGAGCTCCACCAGCAGCCGGGAAGCCCTGCACAC AGCTGGCTATGAGATGTCCCTCAATGGCTGCTCCAGCCCCCTTTTGGACATCGTTGGCGGCCGGAAGGCGAGGCCCCGCCAGTTCCCGTT CCTGGCCTCCATTCAGAATCAAGGCAGGCACTTCTGCGGGGGTGCCCTGATCCATGCCCGCTTCGTGATGACCGCGGCCAGCTGCTTCCA AAGCCAGAACCCCGGGGTTAGCACCGTGGTGCTGGGTGCCTATGACCTGAGGCGGCGGGAGAGGCAGTCCCGCCAGACGTTTTCCATCAG CAGCATGAGCGAGAATGGCTACGACCCCCAGCAGAACCTGAACGACCTGATGCTGCTTCAGCTGGACCGTGAGGCCAACCTCACCAGCAG CGTGACGATACTGCCACTGCCTCTGCAGAACGCCACGGTGGAAGCCGGCACCAGATGCCAGGTGGCCGGCTGGGGGAGCCAGCGCAGTGG GGGGCGTCTCTCCCGTTTTCCCAGGTTTGTCAACGTGACTGTGACCCCCGAGGACCAGTGTCGCCCCAACAACGTGTGCACCGGTGTGCT CACCCGCCGCGGTGGCATCTGCAATGGGGACGGGGGCACCCCCCTCGTCTGCGAGGGCCTGGCCCACGGCGTGGCCTCCTTTTCCCTGGG GCCCTGTGGCCGAGGCCCTGACTTCTTCACCCGAGTGGCGCTCTTCCGAGACTGGATCGATGGTGTTCTCAACAACCCGGGACCGGGGCC AGCCTAGGGGGGCCTGTGACCTCCCATGGAGCCCAGCCCCGCCCTCCACACCTCCGGCGCTCCGCACCCACCTCCCACGGCCCCGCCCCT >523_523_6_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000508983_AZU1_chr19_828230_ENST00000233997_length(amino acids)=765AA_BP=534 MNTSIPYQQNPYNPRGSSNVIQCYRCGDTCKGEVVRVHNNHFHIRCFTCQVCGCGLAQSGFFFKNQEYICTQDYQQLYGTRCDSCRDFIT GEVISALGRTYHPKCFVCSLCRKPFPIGDKVTFSGKECVCQTCSQSMASSKPIKIRGPSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQT CSVILTGEYISKDGVPYCESDYHAQFGIKCETCDRYISGRVLEAGGKHYHPTCARCVRCHQMFTEGEEMYLTGSEVWHPICKQAARAEKK LKHRRTSETSISPPGSSIGSPNRVICAKVDNEILNYKDLAALPKVKSIYEVQRPDLISYEPHSRYMSDEMLERCGYGESLGTLSPYSQDI YENLDLRQRRASSPGYIDSPTYSRQGMSPTFSRSPHHYYRSAGDSNIYRKPPIYKRHGDLSTATKSKTSEDISQTSKYSPIYSPDPYYAS ESEYWTYHGSPKVPRARRFSSGGEEDDFDRSMHKLQSGIGRLILKEEMKARSSSYADPWTPPRSSTSSREALHTAGYEMSLNGCSSPLLD IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDLRRRERQSRQTFSISSMSENGYDPQQNLNDL MLLQLDREANLTSSVTILPLPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNVCTGVLTRRGGICNGDGGTPLV -------------------------------------------------------------- >523_523_7_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000517451_AZU1_chr19_828230_ENST00000233997_length(transcript)=2719nt_BP=1881nt CTAAGCCTCGATTGAAGGAGCACATCCCTTCCATTGAAGCTGCAGAGGAGCAGCTGCCACCCTGTGCACCCACACTTGCTTAAGGGTCTA GCTGGATAACAAAAGGAGGCCCAGAATCGGTGGAGCTTGGAGATGAGCGAAGCAGTCCTGCACCAGGTTCTGAACTAATTAGCTGGTGGA GGGGACAATACGAGTTTAAACAGCGGCTCTGGGTGCCTAAGATTCTACATTTTATACAGACATCCTTGGTTCCAGAGGGGGCTGAGCAGG GGGGTCCGAGGTGAGTCTGTGAGCATGTGCAAGTCTGTACCAGCTTGTGAAGGACATGCCATGTCCCCTGAGTACTCATAGAAAGACACC AACATGACAAAGGTAGTTTGGCTTTATACCTAGAAAAGGCCCCCAGGTCACAAGCTTCTCAGGACTTTGTGGGATTTTCCAGGTGGGCCC TGAGGGGTGGCACTAAAGCAGACTCAAGAGGAGTCTGGGGTGGAGGTGGGTTGCTTGGAAAAGAGGGCGGAGGAAAAAGCTAAATGCAGT CAGCCAGGAGGGGCTGCCCAGGACCCAAGTCAAAGAGAAGAATTTGAAAGCTTTGGAAGCAAGTGCTGTTGTGGGGGCTGCATAGCCCAG GGCTGGCTGAAGCTGATCCACCACGCTCTGCCACTCTGGCTCCACAGAGCACAGAGCTTGTCCCTAAAGCTTCCTGTAGCTGACCATGAG AAATGGTCATGCAGCCACACACACTTCCCCAGCCCCTCTCTCTGCTCTACCAGCCTGTCACCCACGTTTGGGCCACGAGAAGTCACTGCT CTGTAAGTAGTTGTGACTGCAGTGGGTCTTTTTGGTCACCCCTGTCCTGGGCTTACTTCAGGTGGAAGCTTGAAGCTGGATGGCAGCTGA GCCAGCAGACCGATTCTGACACTTACAGATGAGGAAACTAAGGCAGAGATGGTAGGACCTGCCCAGTGTTACAGCTGAGTAAAGTGGCAG AGCTGGGACCAGAACCCAGGTTTGCTGACTCCCTGTCTAGCACTCCTTCCTTCAGGCTATGTAGTCCCTGAGCAGAATGTGGCATCTCAG GTTGTGAGAAATGATGGAGTTCAAATTTATAACAAGGAAGGCTTCTAAAGGGCTAGGAAGGCTTCTAAAGGGCTGGGGCTCACCTGGGAC CTGTCCAGTCTTATTTGAGGAGCCACACCCTTAGAGGTCATTCTGGAACAGACCTGGGAATCCATGGAATGTGCTGGAAAGAGCCCTGGG CTGGGATCTGGTCCAGTTCTGGTGCTCACATGCTATGTGGTCTTAAGCAAGCCCCTTCCCCTCTCTGGTGCTCCAATTACTAAATGCAAA ATGAGGGTTTGGCCCCAGTGCTTTTCCAGCTCCGATGCTCCATGGCCCAGTTCTAACAGAGAGCCCTGATCTTGAAGTGGACTCACTCCC CTGGGCTGGAGCCTGGTAAAGATAGGAAAAGGGTACACAGTCCCATCCCGGTCACTCTGCCTTCCTGAAGTGCTCTCCTTGGGTCCTCTG CAGGTGATTTGTCTACAGCAACCAAGAGCAAAACAAGTGAAGACATCAGCCAGACCTCCAAGTACAGTCCCATCTACTCGCCAGACCCCT ACTATGCTTCGGAGTCTGAGTACTGGACCTACCATGGGTCCCCCAAAGTGCCCCGAGCCAGAAGGTTCTCGTCTGGAGGAGAGGAGGATG ATTTTGACCGCAGCATGCACAAGCTCCAAAGTGGAATTGGCCGGCTGATTCTGAAGGAAGAAATGAAGGCCCGGTCGAGCTCCTATGCAG ATCCCTGGACCCCTCCCCGGAGCTCCACCAGCAGCCGGGAAGCCCTGCACACAGCTGGCTATGAGATGTCCCTCAATGGCTGCTCCAGCC CCCTTTTGGACATCGTTGGCGGCCGGAAGGCGAGGCCCCGCCAGTTCCCGTTCCTGGCCTCCATTCAGAATCAAGGCAGGCACTTCTGCG GGGGTGCCCTGATCCATGCCCGCTTCGTGATGACCGCGGCCAGCTGCTTCCAAAGCCAGAACCCCGGGGTTAGCACCGTGGTGCTGGGTG CCTATGACCTGAGGCGGCGGGAGAGGCAGTCCCGCCAGACGTTTTCCATCAGCAGCATGAGCGAGAATGGCTACGACCCCCAGCAGAACC TGAACGACCTGATGCTGCTTCAGCTGGACCGTGAGGCCAACCTCACCAGCAGCGTGACGATACTGCCACTGCCTCTGCAGAACGCCACGG TGGAAGCCGGCACCAGATGCCAGGTGGCCGGCTGGGGGAGCCAGCGCAGTGGGGGGCGTCTCTCCCGTTTTCCCAGGTTTGTCAACGTGA CTGTGACCCCCGAGGACCAGTGTCGCCCCAACAACGTGTGCACCGGTGTGCTCACCCGCCGCGGTGGCATCTGCAATGGGGACGGGGGCA CCCCCCTCGTCTGCGAGGGCCTGGCCCACGGCGTGGCCTCCTTTTCCCTGGGGCCCTGTGGCCGAGGCCCTGACTTCTTCACCCGAGTGG CGCTCTTCCGAGACTGGATCGATGGTGTTCTCAACAACCCGGGACCGGGGCCAGCCTAGGGGGGCCTGTGACCTCCCATGGAGCCCAGCC CCGCCCTCCACACCTCCGGCGCTCCGCACCCACCTCCCACGGCCCCGCCCCTGCCCCCGCTCCGGCCAGAGGGGCCCTGGCTGTAATAAA >523_523_7_ABLIM3-AZU1_ABLIM3_chr5_148627492_ENST00000517451_AZU1_chr19_828230_ENST00000233997_length(amino acids)=355AA_BP=1 MVLGGHSHVDKPGKTGETPPTALAPPAGHLASGAGFHRGVLQRQWQYRHAAGEVGLTVQLKQHQVVQVLLGVVAILAHAADGKRLAGLPL PPPQVIGTQHHGANPGVLALEAAGRGHHEAGMDQGTPAEVPALILNGGQERELAGPRLPAANDVQKGAGAAIEGHLIASCVQGFPAAGGA PGRGPGICIGARPGLHFFLQNQPANSTLELVHAAVKIILLSSRREPSGSGHFGGPMVGPVLRLRSIVGVWRVDGTVLGGLADVFTCFALG -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ABLIM3-AZU1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ABLIM3-AZU1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ABLIM3-AZU1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ABLIM3 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |